196 related articles for article (PubMed ID: 28361205)
1. Caspase-Cleaved Cytokeratin 18 Fragment M30 as a Potential Biomarker of Macrovascular Invasion in Hepatocellular Carcinoma.
Elalfy H; Besheer T; Arafa MM; El-Hussiny MA; El Latif MA; Alsayed SAM
J Gastrointest Cancer; 2018 Sep; 49(3):260-267. PubMed ID: 28361205
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.
Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A
J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
[TBL] [Abstract][Full Text] [Related]
4. Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion.
Poté N; Cauchy F; Albuquerque M; Voitot H; Belghiti J; Castera L; Puy H; Bedossa P; Paradis V
J Hepatol; 2015 Apr; 62(4):848-54. PubMed ID: 25450201
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Serum Caspase-Cleaved Cytokeratin-18 Levels before Liver Transplantation for One-Year Survival of Patients with Hepatocellular Carcinoma.
Lorente L; Rodriguez ST; Sanz P; Pérez-Cejas A; Padilla J; Díaz D; González A; Martín MM; Jiménez A; Barrera MA
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618033
[TBL] [Abstract][Full Text] [Related]
6. Clinical Utility of Cytokeratins for Accurate Diagnosis of Hepatocellular Carcinoma Among Hepatitis C Virus High-Risk Patients.
Al Haddad M; El-Mezayen HA; El-Kassas M; Metwally F; El-Sharkawy A
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1325-1332. PubMed ID: 38679993
[TBL] [Abstract][Full Text] [Related]
7. Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infection.
Bae CB; Kim SS; Ahn SJ; Cho HJ; Kim SR; Park SY; Song GW; Kim DJ; Hwang SG; Yang JM; Kim YB; Park YN; Shin SJ; Cho SW; Cheong JY
J Clin Virol; 2013 Dec; 58(4):641-6. PubMed ID: 24210327
[TBL] [Abstract][Full Text] [Related]
8. High Circulating Caspase-Cleaved Keratin 18 Fragments (M30) Indicate Short-Term Mortality in Critically Ill Patients.
Koch A; Yagmur E; Linka J; Schumacher F; Bruensing J; Buendgens L; Herbers U; Koek GH; Weiskirchen R; Trautwein C; Tacke F
Dis Markers; 2018; 2018():8583121. PubMed ID: 30069276
[TBL] [Abstract][Full Text] [Related]
9. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
10. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
[TBL] [Abstract][Full Text] [Related]
11. Serum Insulin-Like Growth Factor-1 (IGF-1): a Novel Prognostic Factor for Early Recurrence of Hepatocellular Carcinoma (HCC).
Yao Y; Mao W; Dong M; Yang D; Li W; Chen Y
Clin Lab; 2017 Feb; 63(2):261-270. PubMed ID: 28182337
[TBL] [Abstract][Full Text] [Related]
12. Prediction of vascular invasion in hepatocellular carcinoma by next-generation des-r-carboxy prothrombin.
Kurokawa T; Yamazaki S; Mitsuka Y; Moriguchi M; Sugitani M; Takayama T
Br J Cancer; 2016 Jan; 114(1):53-8. PubMed ID: 26679378
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma.
Sun Y; Zhu S; Wu Z; Huang Y; Liu C; Tang S; Wei L
Oncotarget; 2017 Apr; 8(14):23427-23435. PubMed ID: 28178643
[TBL] [Abstract][Full Text] [Related]
14. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
15. New scoring system for prediction of microvascular invasion in patients with hepatocellular carcinoma.
Shirabe K; Toshima T; Kimura K; Yamashita Y; Ikeda T; Ikegami T; Yoshizumi T; Abe K; Aishima S; Maehara Y
Liver Int; 2014 Jul; 34(6):937-41. PubMed ID: 24393295
[TBL] [Abstract][Full Text] [Related]
16. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
[TBL] [Abstract][Full Text] [Related]
17. AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma.
Kwon JH; Ahn KS; Moon YH; Park JY; Wang HJ; Choi KY; Kim G; Joh JW; Lee KG; Kang KJ
J Korean Med Sci; 2015 Sep; 30(9):1253-9. PubMed ID: 26339164
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma.
Sadeghi M; Lahdou I; Oweira H; Daniel V; Terness P; Schmidt J; Weiss KH; Longerich T; Schemmer P; Opelz G; Mehrabi A
Br J Cancer; 2015 Sep; 113(5):756-62. PubMed ID: 26270232
[TBL] [Abstract][Full Text] [Related]
19. Serum Caspase-Cleaved Cytokeratin (M30) Indicates Severity of Liver Dysfunction and Predicts Liver Outcome.
Oweira H; Sadeghi M; Volker D; Mieth M; Zidan A; Khajeh E; Ghamarnejad O; Fonouni H; Weiss KH; Schmidt J; Lahdou I; Mehrabi A
Ann Transplant; 2018 Jun; 23():393-400. PubMed ID: 29880786
[TBL] [Abstract][Full Text] [Related]
20. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
Leerapun A; Suravarapu SV; Bida JP; Clark RJ; Sanders EL; Mettler TA; Stadheim LM; Aderca I; Moser CD; Nagorney DM; LaRusso NF; de Groen PC; Menon KV; Lazaridis KN; Gores GJ; Charlton MR; Roberts RO; Therneau TM; Katzmann JA; Roberts LR
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):394-402; quiz 267. PubMed ID: 17368240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
